Jill MacAlpine

Background

About Jill MacAlpine

After 15 years in patent law, I have broad experience in all aspects of the field, including patent litigation, counseling, and prosecution, primarily in the chemical and pharmaceutical areas. A significant portion of my practice is devoted to pre-litigation analyses, due diligence investigations, opinion preparation, and strategic client counseling, including patent portfolio management, Orange Book listings of patents covering FDA-approved drugs, and patent term extensions. As a registered patent attorney, I also have extensive experience in handling a wide variety of patent matters before the U.S. Patent and Trademark Office (USPTO), including post-grant proceedings specifically IPRs, appeals, and oral hearings at the Patent Trial and Appeal Board (PTAB); drafting and prosecution of patent applications; reissue and reexamination proceedings; and interferences. In addition to counseling and prosecution, I also have experienced with patent litigation, in particular Abbreviated New Drug Application (ANDA) cases arising under the Hatch-Waxman Act. Specifically, I have experience in all aspects of patent litigation, at both U.S. district court and appellate levels, including managing day-to-day activities during every phase of litigation, conducting offensive and defensive discovery, drafting dispositive motions, and taking and defending depositions.